UDG Healthcare Public Limited Co. Notice of Interim Results (6463M)
May 01 2018 - 2:00AM
UK Regulatory
TIDMUDG
RNS Number : 6463M
UDG Healthcare Public Limited Co.
01 May 2018
1 May 2018
UDG Healthcare plc
Notice of Interim Results
UDG Healthcare plc ("the Group"), a leading international
healthcare services provider, will issue its interim results for
the half year ended 31 March 2018 at 07:00am (BST) on Tuesday 22
May 2018.
Management will be hosting a presentation for analysts and
investors at the London Stock Exchange at 08:30am (BST) to discuss
the company's half year results and provide an update on each of
the Group's divisions.
Analysts and investors wishing to attend are asked to contact
Powerscourt on the details below, as all attendees need to be
pre-registered. The presentation will also be available via live
audio webcast and conference call, the details of which are
below.
Audio webcast:
https://edge.media-server.com/m6/p/hporn254
Conference call dial-in details:
UK +44 (0)330 336 9105
-------------------------- --------------------
Ireland +353 (0)1 246 5638
-------------------------- --------------------
United States of America +1 929-477-0448
-------------------------- --------------------
Participant Code 6327399
-------------------------- --------------------
For further information, please contact:
UDG Healthcare plc
Keith Byrne
Head of Investor Relations, Strategy
& Corporate Communications
Tel: +353-1-468-9000
Powerscourt
Lisa Kavanagh / Isabelle Saber /
Sam Austrums
Tel: +44-207-250-1446
udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering advisory, communication, commercial, clinical
and packaging services to the healthcare industry, employing 9,000
people with operations in 24 countries and delivering services in
over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for
the pharmaceutical and healthcare industry, operating across three
areas of activity: advisory, communication, commercial &
clinical services. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
Ashfield provides field and contact centre sales teams, healthcare
communications, patient support, audit, advisory, medical
information and event management services to over 300 healthcare
companies.
Sharp is a global leader in contract commercial packaging and
clinical trial supply chain solutions services for the
pharmaceutical and biotechnology industries, operating from
state-of-the-art facilities in the US and Europe.
Aquilant is leading distributor of specialist medical and
scientific products, providing outsourced sales, marketing,
distribution and engineering services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORSDLFMSFASEEL
(END) Dow Jones Newswires
May 01, 2018 02:00 ET (06:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024